|
ZNF187 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.54359999729559E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19619869565213E-11 |
| Normal-vs-Stage2 |
3.335700E-02 |
| Normal-vs-Stage3 |
2.664600E-03 |
| Normal-vs-Stage4 |
1.391980E-01 |
| Stage1-vs-Stage2 |
1.477980E-01 |
| Stage1-vs-Stage3 |
1.696470E-02 |
| Stage1-vs-Stage4 |
9.024000E-04 |
| Stage2-vs-Stage3 |
8.038600E-01 |
| Stage2-vs-Stage4 |
2.887800E-01 |
| Stage3-vs-Stage4 |
2.515800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.49719961060202E-10 |
| Normal-vs-AfricanAmerican |
2.843200E-01 |
| Normal-vs-Asian |
4.037800E-02 |
| Caucasian-vs-AfricanAmerican |
3.811900E-02 |
| Caucasian-vs-Asian |
2.926200E-01 |
| AfricanAmerican-vs-Asian |
6.871700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.02579999999397E-05 |
| Normal-vs-Female |
1.93669968950871E-10 |
| Male-vs-Female |
3.356300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.302400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.64139998762403E-09 |
| Normal-vs-Age(61-80Yrs) |
1.84630999999769E-05 |
| Normal-vs-Age(81-100Yrs) |
1.897630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.794200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.223400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.064200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.128200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.895600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.754200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.608500E-04 |
| Normal-vs-Grade 2 |
3.29292149103821E-13 |
| Normal-vs-Grade 3 |
3.592100E-04 |
| Normal-vs-Grade 4 |
7.076600E-01 |
| Grade 1-vs-Grade 2 |
5.153800E-02 |
| Grade 1-vs-Grade 3 |
4.246800E-04 |
| Grade 1-vs-Grade 4 |
2.0869000000312E-06 |
| Grade 2-vs-Grade 3 |
2.024200E-04 |
| Grade 2-vs-Grade 4 |
1.24000000045754E-07 |
| Grade 3-vs-Grade 4 |
5.077100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.6242562850266E-12 |
| Normal-vs-ccB subtype |
1.506220E-01 |
| ccA subtype-vs-ccB subtype |
1.00652819412517E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.2888999967895E-08 |
| Normal-vs-N1 |
1.291150E-01 |
| N0-vs-N1 |
1.884110E-03 |
|
|
